Sagar Dhamne, MBBS, MD
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Sagar Dhamne
I am an Anatomic Pathologist with expertise in Breast diseases and Breast cancer. Within the breast lesions my clinical interests are papillary lesions of the breast, and radiology-pathology correlation, especially focusing how MRI breast findings correlate with histology findings. As a research scientist I am interested in elucidating molecular underpinnings of early stages of breast cancer especially DCIS and application of new emerging technologies like AI to the field of pathology. I frequently collaborate with clinical colleagues in clinical trial protocols focusing in treatment of hormone receptor positive breast carcinomas. I am also involved in the trainee education and serve on intra-departmental educational committees. I am the Chair of the Residents’ and Fellows’ Seminar committee at the Texas Society of Pathologists (TSP) entrusted with encouraging and furthering pathology education in Texas. I strongly advocate for the field of pathology being a Delegate representing the State of Texas in the College of American Pathologists (CAP) House of Delegate.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Pathology and Laboratory Medicine, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, Texas
Adjunct Associate Professor, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas
Education & Training
Degree-Granting Education
| 2008 | Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, IN, Pathology, MD |
| 2004 | Byramjee Jeejeebhoy Medical College, Pune, Maharashtra, IN, Medicine, MBBS |
Postgraduate Training
| 2014-2015 | Postgraduate Fellow, Breast Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois |
| 2010-2014 | Resident, Pathology (AP/CP), Baylor College of Medicine, Houston, Texas |
| 2003-2003 | Intern, Sassoon General Hospitals, Pune, Maharashtra |
Experience & Service
Academic Appointments
Associate Professor, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2023 - 2024
Assistant Professor, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2016 - 2023
Administrative Appointments/Responsibilities
Director, Department of Pathology and Laboratory Medicine, Ben Taub General Hospital, Houston, Texas, 2023 - 2024
Director Baylor Citywide Pathology Grand Rounds Committee (AP), Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2020 - 2024
Director of Breast Pathology Trainee Elective Rotation, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2017 - 2024
Chief Resident in Pathology, Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, 2013 - 2014
Institutional Committee Activities
Member, Clinical Curriculum Committee, 2024 - Present
Director, Quality Assurance and Performance Improvement, 2023 - 2024
Member, Laboratory Performance Improvement Committee, 2023 - 2024
Chair, Residents' and Fellows' Seminar Committee, 2022 - Present
Member, Clinical Curriculum Committee, 2020 - 2024
Member, Resident and Fellows Seminar Committee, 2019 - 2022
Honors & Awards
| 2022 | O'neal Spjut Award for Leadership and Unselfish Commitment to Department Mission, Department of Pathology & Immunology, Baylor College of Medicine |
| 2021 | Norton Rose Fulbright Faculty Excellence Award - Teaching and Evaluation, Baylor College of Medicine |
| 2021 | Professional educator Appreciation and Recognition Award (PEAR), Baylor College of Medicine |
| 2019 | Faculty Award for Outstanding Resident Teaching - Anatomic Pathology, Department of Pathology & Immunology |
| 2019 | Early Career Faculty Award for Excellence in Patient Care, Baylor College of Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Young, A, Bu, W, Jiang, W, Ku, AT, Kapali, J, Dhamne, S, Qin, L, Hilsenbeck, SG, Du, YN, Li, Y. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Cancer Prevention Research 15(1):3-10, 2022. e-Pub 2022. PMID: 34667127.
- McLemore LE, Albarracin CT, Dhamne S, Chen H. Her2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines. Breast Cancer Res Treat 187(1):95-104, 2021. e-Pub 2021. PMID: 33813685.
- Gadgil NM, Dhamne S. Clinicopathological Study of nephrotic syndrome in Indian children: A tertiary care experience. Annals of Pathol and Lab Med 4(1):A28-38, 2017. e-Pub 2017.
- Dhamne S, Soundars E, Zarrin-Khameh N. Pathologic findings in women with atypical glandular cells on Pap test. J Am Soc Cytopathol 5(1):50-55, 2016. e-Pub 2016. PMID: 31042539.
- Kander E, Raza S, Dhamne S, Solari M, Jain S. Adenoid cystic carcinoma of the breast from a single-center cohort. Cancer Treat Commun 4:182-187, 2015. e-Pub 2015.
- Dhamne S, Brown RE, Covinsky M, Dhamne CA, Tatevian N. Clear cell sarcoma of kidney: morphoproteomic analysis reveals genomic correlates and therapeutic options. Pediatr Dev Pathol 16(1):20-27, 2013. e-Pub 2013. PMID: 22256788.
Invited Articles
- Dhamne S, Albarracin CT. Ki67 as a Biomarker of Prognosis and Prediction: Is it Ready for Use in Routine Pathology Practice?. Curr Breast Cancer Rep 6(4):260-266, 2014. e-Pub 2014.
- Dhamne S, Albarracin CT. Evolving Role of Ki67 as a Predictive and Prognostic Marker in Breast Cancer. J Clin Exp Pathol 4(5):e117, 2014. e-Pub 2014.
Other Articles
- Sellers, CM, Ortiz-Perez, T, Dhamne, S, Roark, A, Gilman, L Intramammary Metastases from Extramammary Malignancies. Current Breast Cancer Reports 15(2):85-96, 2023.
- Villanueva H, Dhamne S, Edwards D The emerging role of steroid hormone receptors in Ductal carcinoma in situ of the breast. J Mammary Gland Biol Neoplasia 23(4):237-248, 2018. PMID: 30338425.
- Phalak K, Sedgwick EL, Dhamne S, Gutierrez C AIRP best cases in radiologic-pathologic correlation: malignant phyllodes tumor with osteosarcomatous differentiation. Radiographics 33(5):1377-81, 2013. PMID: 24025930.
- Schechet SA, Askenasy EP, Dhamne S, Scott BG Anemia and jejunal intussusception: An unusual presentation for a metastatic phyllodes breast tumor. Int J Surg Case Rep 3(2):62-64, 2012. PMID: 22288047.
- Dhamne S, Gadgil NM, Padmanabhan A Leiomyosarcoma of the renal pelvis. Indian J of Pathol Microbiol 52(4):549-51, 2009. PMID: 19805970.
Abstracts
- Dhamne S, Nangia J, Osborne CK, Schiff R, Rimawi M. Biomarkers of response to neoadjuvant endocrine therapy with Anastrozole alone or in combination with fulvestrant in ER-positive Her 2 negative breast cancers (PACT-01 trial).
- McLemore LE, Dhamne S, Albarracin CT. Her 2 testing in breast cancers: Comparison of Assays and Interpretation Using ASCO-CAP 2013 and 2018 guidelines. USCAP annual meeting.
- Dhamne S, Albarracin CT. Estrogen receptor immunohistochemical staining versus Oncotype Dx: Clinicopathologic characteristics and recurrence scores of concordant and discordant cases. USCAP annual meeting.
- Goetz L, Powell J, McGowan L, Dhamne S. Changing Clinicopathologic features of malignant phyllodes tumors in the setting of COVID-19 pandemic: Size Matters. USCAP Annual Meeting.
- Taha h, Shitawi M, Dhamne S. Encapsulated papillary carcinoma in male breast: a rare case. Texas Society of Pathology Annual Meeting.
- Platero-Portillo t, Taha, H, Shitawi M, Dhamne S. The role of MRI-guided Biopsy in Breast cancer diagnosis and patient monitoring - A single institution analysis. USCAP Annual Meeting 2024.
- Wang JC, Dhamne S, Shitawi M, Taha H, Zhang S. Phyllodes Tumor of The Breast in Hispanic Population: A Clinicopathological Study of 226 Cases. USCAP Annual Meeting 2025.
- Alrohaibani A, Dhamne S, Albarracin CT, Arun B, Chen H. ESR1 Mutated Advanced Breast Cancer: Clinicopathological and Molecular Characteristics. USCAP Annual Meeting 2025.
Selected Presentations & Talks
Local Presentations
- 2025. Papillary lesions of the breast and utility of immunohistochemistry in these lesions. Invited. Breast Pathology Lecture Series. Houston, Texas, US.
- 2020. Biomarker analysis in breast cancers: Recent updates. Invited. Citywide Baylor Pathology Grand Rounds. Houston, Texas, US.
- 2019. Endocrine therapy in the treatment of ER positive breast cancers. Invited. Trainee Research Symposium. Houston, Texas, US.
- 2017. A comparison of Breast Cancers' Radiologic, Macroscopic and Microscopic Imagery. Invited. All-City Anatomic Pathology Symposium. Houston, Texas, US.
- 2016. Her2 overexpression in Breast Carcinomas. Invited. Citywide Baylor Pathology Grand Rounds. Houston, Texas, US.
National Presentations
- 2022. Clinical Practice Updates in Fibroepithelial Lesions of the Breast. Invited. AP/CP Grand Rounds, Department of Pathology and Laboratory Medicine. Madison, Wisconsin, US.
International Presentations
- 2021. Breast Pathology: What the surgeon needs to know. Invited. Virtual, IN.
- 2021. Papillary lesions of the breast. Invited. 2021 Annual Conference of the Latin American Society of Pathology (SLAP). Virtual, CR.
Patient Reviews
CV information above last modified May 12, 2025